Skip to results
Modify your search
NARROW
1-20 of 179
Authors: Mark R. Gilbert
Journal Article
ACCEPTED MANUSCRIPT
Establishing the content validity of Patient-Reported Outcome measures used in neuro-oncology based on the WHO ICF framework: part of the RANO-PRO initiative
Neuro-Oncology, noaf108, https://doi.org/10.1093/neuonc/noaf108
Published: 28 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Prevalence of symptomatic toxicities for novel therapies in adult oncology trials: A scoping review
JNCI Cancer Spectrum, pkaf036, https://doi.org/10.1093/jncics/pkaf036
Published: 27 March 2025
Journal Article
ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History Study
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf002, https://doi.org/10.1093/noajnl/vdaf002
Published: 16 January 2025
Journal Article
cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics
Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdae228, https://doi.org/10.1093/noajnl/vdae228
Published: 03 January 2025
Journal Article
Implications of sociodemographic and clinical factors on symptom burden: Age-specific survivorship care in the primary central nervous system tumor population Get access
Neuro-Oncology Practice, npae116, https://doi.org/10.1093/nop/npae116
Published: 26 November 2024
Journal Article
Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825 Get access
Neuro-Oncology, Volume 27, Issue 3, March 2025, Pages 767–778, https://doi.org/10.1093/neuonc/noae234
Published: 16 November 2024
Journal Article
NCOG-28. SERUM PROTEIN BIOMARKERS LINKED TO NEURODEGENERATIVE PROCESSES ARE ELEVATED IN GLIOMA PATIENTS AND ASSOCIATED WITH SEVERITY OF NEUROLOGIC SYMPTOMS
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii230, https://doi.org/10.1093/neuonc/noae165.0910
Published: 11 November 2024
Journal Article
NCOG-27. HIGHER LEVELS OF SERUM ICAM-1 AND IL-10 ARE ASSOCIATED WITH COGNITIVE DYSFUNCTION IN BOTH IDH-WILDTYPE AND IDH-MUTANT GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii230, https://doi.org/10.1093/neuonc/noae165.0909
Published: 11 November 2024
Journal Article
CTIM-03. IMMUNE CHECKPOINT INHIBITOR NIVOLUMAB IN PEOPLE WITH RECURRENT SELECT RARE CNS CANCERS: RESULTS OF INTERIM ANALYSIS IN A NON-HEAVILY PRETREATED COHORT
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii85, https://doi.org/10.1093/neuonc/noae165.0337
Published: 11 November 2024
Journal Article
PATH-55. RAMAN-BASED MACHINE LEARNING PLATFORM REVEALS UNIQUE METABOLIC DIFFERENCES BETWEEN IDHMUT AND IDHWT GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii191, https://doi.org/10.1093/neuonc/noae165.0754
Published: 11 November 2024
Journal Article
Neighborhood disadvantage is associated with treatment access outcomes and survival among individuals with a primary brain tumor Get access
Neuro-Oncology Practice, Volume 12, Issue 2, April 2025, Pages 313–324, https://doi.org/10.1093/nop/npae101
Published: 04 November 2024
Journal Article
Sleep disorders associated with cranial radiation—A systematic review Get access
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 63–76, https://doi.org/10.1093/neuonc/noae174
Published: 28 October 2024
Journal Article
Disparities in the availability of and access to neuro-oncology trial-supporting infrastructure in the United States Get access
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 3, March 2025, Pages 511–516, https://doi.org/10.1093/jnci/djae240
Published: 26 September 2024
Journal Article
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas
Neuro-Oncology, Volume 27, Issue 2, February 2025, Pages 319–330, https://doi.org/10.1093/neuonc/noae170
Published: 30 August 2024
Journal Article
Distinct relapse pattern across molecular ependymoma types Get access
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 267–276, https://doi.org/10.1093/neuonc/noae166
Published: 22 August 2024
Journal Article
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendations
Neuro-Oncology Practice, Volume 12, Issue 1, February 2025, Pages 76–86, https://doi.org/10.1093/nop/npae067
Published: 19 July 2024
Journal Article
Pathways to hypermutation in high-grade gliomas: Mechanisms, syndromes, and opportunities for immunotherapy
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae105, https://doi.org/10.1093/noajnl/vdae105
Published: 24 June 2024
Journal Article
EPID-01. ESTIMATING THE BURDEN DUE TO BRAIN AND OTHER CNS TUMORS IN ADOLESCENTS IN THE UNITED STATES
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.233
Published: 18 June 2024
Journal Article
EPEN-01. DISTINCT RELAPSE PATTERN ACROSS MOLECULAR EPENDYMOMA TYPES
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.203
Published: 18 June 2024
Journal Article
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma Get access
Neuro-Oncology, Volume 26, Issue 9, September 2024, Pages 1628–1637, https://doi.org/10.1093/neuonc/noae058
Published: 14 June 2024
